# Avidia

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/avidia

- Industry: Biotechnology
- Headquarters: Mountain View, US
- Total disclosed funding: $72M
- Latest round: Series C (May 8, 2006)
- Investors on record: 7

## About

Founded in 2003 and based in the US, Avidia, Inc. engages in the discovery and development of therapeutic proteins to address the areas of autoimmunity, inflammation, neurology and oncology.

## Funding rounds

- Series C, May 8, 2006, $22M — Alloy Ventures, HealthCare Ventures, Morgenthaler Ventures, TPG, Skyline Ventures, Amgen Ventures, MedImmune Ventures
- Series C, May 4, 2006, $22M — Morgenthaler Ventures
- Series B, May 1, 2005, $29M — Amgen Ventures, MedImmune Ventures

## Investors

- Amgen Ventures (https://capitalatlas.ai/funds/amgen-ventures) — Series B, Series C
- MedImmune Ventures (https://capitalatlas.ai/funds/medimmune-ventures) — Series B, Series C
- Morgenthaler Ventures (https://capitalatlas.ai/funds/morgenthaler-ventures) — Series C
- Alloy Ventures (https://capitalatlas.ai/funds/alloy-ventures) — Series C
- HealthCare Ventures — Series C
- TPG (https://capitalatlas.ai/funds/tpg) — Series C
- Skyline Ventures (https://capitalatlas.ai/funds/skyline-ventures) — Series C